In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 74 for your search:
Drug:  bicalutamide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: D6876C00001, NCT00293696

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 40 to 90
Sponsor: Pharmaceutical / Industry
Protocol IDs: AVO108943, NCT00470834

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: SWOG-S9615, SWOG-9615, S9615

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI, Other
Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: RTOG-9601, CDR0000065158, RTOG-R9601, NCT00002874

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: RTOG-9608, RTOG-96-08

7.

Phase: Phase III
Type: Health services research, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: EORTC-22961, EORTC-GU-22961, NCT00003026

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-98092, ZENECA-7054US/0007, NCI-G99-1494

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: RTOG-9902, CDR0000067250, RTOG-DEV-1020, NCT00004054

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9910, CDR0000067635, NCT00005044

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 80 and under
Sponsor: Other
Protocol IDs: CDR0000068749, EORTC-22991, NCT00021450

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: RTOG-P-0011, CDR0000068868, RTOG-DEV-1037, CAN-NCIC-PR9, PR9, NCT00023829

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-P-0014, CDR0000069186, RTOG-DEV-1028, ECOG-RTOG-P-0014, CALGB-RTOG-P-0014, SWOG-RTOG-P-0014, NCT00030654

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 30 and over
Sponsor:
Protocol IDs: UCLA-9002048, NCI-V90-0176

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CRC-TU-PR3003, EU-90044

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: MSKCC-92050, NCI-V92-0124

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CRC-TU-PR3005, EU-92015

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 80
Sponsor: Other
Protocol IDs: CDR0000270970, FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731

19.

Phase: Phase III
Type: Natural history/Epidemiology, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 03-040, P30CA008748, MSKCC-03040, NCT00067015

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000353209, U10CA031946, CALGB-90202, CAN-NCIC-PRC2, ECOG-CALGB-90202, SWOG-CALGB-90202, NCT00079001

21.

Phase: Phase III
Type: Prevention, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: 7054IT/0003, NCT00233610

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: No age specified
Sponsor: Other
Protocol IDs: 05-8-4, NCT00243646

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0521, CDR0000462375, NCI-2009-00728, NCT00288080

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS30, 2008-005232-33, NCT00833248

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS31, 2008-008604-40, NCT00884273
1    
New Search